CLINICAL EVALUATION OF 1-BETA-D-RIBOFURANOSYL-124-TRIAZOLE-3-CARBOXAMIDE (RIBAVIRIN) IN A DOUBLE-BLIND-STUDY DURING AN OUTBREAK OF INFLUENZA

Simple item page
dc.contributor.authorSALIDO RENGELL, F
dc.contributor.authorNASSER QUINONES, H
dc.contributor.authorBRISENOGARCIA, B
dc.date.accessioned2026-05-28T15:50:26Z
dc.date.issued1959
dc.description.paginacion272 - 277
dc.description.procedenciaEXT
dc.format.discursoArtículo
dc.format.extent6
dc.identifier.issn0077-8923
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/19415
dc.language.isoInglés
dc.numero.secuencia19412
dc.publisherNATL INST VIROL,MEXICO CITY,MEXICO
dc.relation.ispartofseriesVol. 284
dc.source.revistafuenteANNALS OF THE NEW YORK ACADEMY OF SCIENCES
dc.subjectCLINICAL, EVALUATION, BETA, RIBOFURANOSYL, TRIAZOLE, CARBOXAMIDE, RIBAVIRIN, DOUBLE-BLIND-STUDY, OUTBREAK, INFLUENZA
dc.subject.categoriaprincipalMULTIDISCIPLINARIA
dc.subject.disciplinaCIENCIAS CLINICAS
dc.subject.subdisciplinaPATOLOGIA CLINICA
dc.titleCLINICAL EVALUATION OF 1-BETA-D-RIBOFURANOSYL-124-TRIAZOLE-3-CARBOXAMIDE (RIBAVIRIN) IN A DOUBLE-BLIND-STUDY DURING AN OUTBREAK OF INFLUENZA
dc.title.alternativeANN N Y ACAD SCI

Files

Collections

Registros completos